메뉴 건너뛰기




Volumn 115, Issue 3, 2005, Pages 484-492

Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells

Author keywords

Chemotherapy; COL 3; Combination therapy; Cyclooxygenase 2 celecoxib; Prostate cancer; Taxotere

Indexed keywords

4 DEDIMETHYLAMINOSANCYCLINE; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DOCETAXEL; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAD; PROTEIN BCL XL; X LINKED INHIBITOR OF APOPTOSIS;

EID: 18644380058     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20878     Document Type: Article
Times cited : (99)

References (67)
  • 2
    • 0037639101 scopus 로고    scopus 로고
    • Multidrug resistance in prostate cancer
    • van Brussel JP, Mickinsch GH. Multidrug resistance in prostate cancer. Onkologie 2003;26:175-81.
    • (2003) Onkologie , vol.26 , pp. 175-181
    • Van Brussel, J.P.1    Mickinsch, G.H.2
  • 3
    • 0344825374 scopus 로고    scopus 로고
    • Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death
    • Hazelhurst LA, Landowski TH, Dalton WS. Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death. Onocogene 2003;22:7396-402.
    • (2003) Onocogene , vol.22 , pp. 7396-7402
    • Hazelhurst, L.A.1    Landowski, T.H.2    Dalton, W.S.3
  • 4
    • 0037064039 scopus 로고    scopus 로고
    • Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2
    • Patel VA, Dunn MJ, Sorokin A. Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2. J Biol Chem 2002;277:38915-20.
    • (2002) J Biol Chem , vol.277 , pp. 38915-38920
    • Patel, V.A.1    Dunn, M.J.2    Sorokin, A.3
  • 6
    • 0036735391 scopus 로고    scopus 로고
    • Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing in human colon cancer cells
    • Tang X, Sun YJ, Half E, Kuo MT, Sinicrope F. Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing in human colon cancer cells. Cancer Res 2002;62:4903-8.
    • (2002) Cancer Res , vol.62 , pp. 4903-4908
    • Tang, X.1    Sun, Y.J.2    Half, E.3    Kuo, M.T.4    Sinicrope, F.5
  • 7
    • 0036829336 scopus 로고    scopus 로고
    • Cylcloxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells
    • Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA. Cylcloxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res 2002;6:6323-8.
    • (2002) Cancer Res , vol.6 , pp. 6323-6328
    • Sun, Y.1    Tang, X.M.2    Half, E.3    Kuo, M.T.4    Sinicrope, F.A.5
  • 11
    • 0021288454 scopus 로고
    • Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients
    • Baich CM, Doghert PA, Cloud GA. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients. Surgery 1984;95:71-7.
    • (1984) Surgery , vol.95 , pp. 71-77
    • Baich, C.M.1    Doghert, P.A.2    Cloud, G.A.3
  • 12
    • 0033973713 scopus 로고    scopus 로고
    • Molecular pathology of cyclooxygenase-2 in neoplasia and xenobiotic oxidation
    • Fosslien E. Molecular pathology of cyclooxygenase-2 in neoplasia and xenobiotic oxidation. Ann Clin Lab Sci 2000;30:3-21.
    • (2000) Ann Clin Lab Sci , vol.30 , pp. 3-21
    • Fosslien, E.1
  • 13
    • 0033988665 scopus 로고    scopus 로고
    • Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma
    • Gupta S, Srivastava M, Ahmad N. Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate 2000;42:73-8.
    • (2000) Prostate , vol.42 , pp. 73-78
    • Gupta, S.1    Srivastava, M.2    Ahmad, N.3
  • 14
    • 0003504049 scopus 로고    scopus 로고
    • Cyclooxysenase regulates angiogenesis induced by colon cancer cells
    • Tsuji M, Kawano S, Tsuji S, Sawaoka H, Hori M, Dubois RN. Cyclooxysenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705-16.
    • (1998) Cell , vol.93 , pp. 705-716
    • Tsuji, M.1    Kawano, S.2    Tsuji, S.3    Sawaoka, H.4    Hori, M.5    Dubois, R.N.6
  • 16
    • 0035866783 scopus 로고    scopus 로고
    • Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells
    • Subbarayan V, Sabichi AL, Llansa N, Lippman SM, Menter DG. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells. Cancer Res 2001;61:2720-6.
    • (2001) Cancer Res , vol.61 , pp. 2720-2726
    • Subbarayan, V.1    Sabichi, A.L.2    Llansa, N.3    Lippman, S.M.4    Menter, D.G.5
  • 17
    • 0033781990 scopus 로고    scopus 로고
    • Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: Implications for prevention and treatment
    • Madaan S, Abel PD, Chaudhary KS, Hewitt R, Stott MA, Stamp GWH, Lalani EN. Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment. Br J Urol Internatl 2000;86:736-41.
    • (2000) Br J Urol Internatl , vol.86 , pp. 736-741
    • Madaan, S.1    Abel, P.D.2    Chaudhary, K.S.3    Hewitt, R.4    Stott, M.A.5    Stamp, G.W.H.6    Lalani, E.N.7
  • 18
    • 0035104125 scopus 로고    scopus 로고
    • Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer
    • Uotila P, Valve E, Martikaninen P, Nevalainen M, Nurmi M, Harkonen P. Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer. Urol Res 2001;29:25-8.
    • (2001) Urol Res , vol.29 , pp. 25-28
    • Uotila, P.1    Valve, E.2    Martikaninen, P.3    Nevalainen, M.4    Nurmi, M.5    Harkonen, P.6
  • 19
    • 0034898976 scopus 로고    scopus 로고
    • The role of cyclooxygenase-2 in prostate cancer
    • Kirschenbaum A, Liu XH, Yao S, Levine AC. The role of cyclooxygenase-2 in prostate cancer. Urology 2001;58:127-31.
    • (2001) Urology , vol.58 , pp. 127-131
    • Kirschenbaum, A.1    Liu, X.H.2    Yao, S.3    Levine, A.C.4
  • 20
    • 0345505237 scopus 로고    scopus 로고
    • Cyclooxygenase-2 in prostate carcinogenesis
    • Hussain T, Gupta S, Mukhtar H. Cyclooxygenase-2 in prostate carcinogenesis. Cancer Lett 2003;191:125-35.
    • (2003) Cancer Lett , vol.191 , pp. 125-135
    • Hussain, T.1    Gupta, S.2    Mukhtar, H.3
  • 21
    • 0034646688 scopus 로고    scopus 로고
    • The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2
    • Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM, Chen CS. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem 2000;275:11397-403.
    • (2000) J Biol Chem , vol.275 , pp. 11397-11403
    • Hsu, A.L.1    Ching, T.T.2    Wang, D.S.3    Song, X.4    Rangnekar, V.M.5    Chen, C.S.6
  • 22
    • 0032838954 scopus 로고    scopus 로고
    • Interaction between stromal cells and tumor cells induces chemoresistance and matrix metalloproteinase secretion
    • Zhu B, Block N, Lokeshwar BL. Interaction between stromal cells and tumor cells induces chemoresistance and matrix metalloproteinase secretion. Ann NY Acad Sci 1999;878:642-6.
    • (1999) Ann NY Acad Sci , vol.878 , pp. 642-646
    • Zhu, B.1    Block, N.2    Lokeshwar, B.L.3
  • 24
    • 0031401163 scopus 로고    scopus 로고
    • Stromal-epithelia interactions in the normal and neoplastic prostate
    • Hayward SW, Rosen MA, Cunha GR. Stromal-epithelia interactions in the normal and neoplastic prostate. Br J Urol 1997;79:18-26.
    • (1997) Br J Urol , vol.79 , pp. 18-26
    • Hayward, S.W.1    Rosen, M.A.2    Cunha, G.R.3
  • 25
    • 0035418579 scopus 로고    scopus 로고
    • Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblasts
    • Pinski J, Parikh A, Bova GS, Isaacs JT. Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblasts. Cancer Res 2001;61:6372-6.
    • (2001) Cancer Res , vol.61 , pp. 6372-6376
    • Pinski, J.1    Parikh, A.2    Bova, G.S.3    Isaacs, J.T.4
  • 26
    • 0035695542 scopus 로고    scopus 로고
    • The challenge of pathway and environment-mediated drug resistance
    • Sausville EA. The challenge of pathway and environment-mediated drug resistance. Cancer Metastasis Rev 2001;20:117-22.
    • (2001) Cancer Metastasis Rev , vol.20 , pp. 117-122
    • Sausville, E.A.1
  • 27
    • 0029916720 scopus 로고    scopus 로고
    • In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines
    • Sokoloff MH, Tso CL, Kaboo R, Taneja S, Pang S, deKernion JB, Belldegrun AS. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines. Cancer 1996;77:1862-72.
    • (1996) Cancer , vol.77 , pp. 1862-1872
    • Sokoloff, M.H.1    Tso, C.L.2    Kaboo, R.3    Taneja, S.4    Pang, S.5    DeKernion, J.B.6    Belldegrun, A.S.7
  • 30
    • 0343674119 scopus 로고    scopus 로고
    • A Validated LC method for quantitative determination of celecoxib in pharmaceutical dosage forms and purity evaluation in bulk drugs
    • Srinivasu MK, Narayana CL, Roa DS, Reddy GO. A Validated LC method for quantitative determination of celecoxib in pharmaceutical dosage forms and purity evaluation in bulk drugs. J Pharm Biomed Anal 2000;22:949-56.
    • (2000) J Pharm Biomed Anal , vol.22 , pp. 949-956
    • Srinivasu, M.K.1    Narayana, C.L.2    Roa, D.S.3    Reddy, G.O.4
  • 31
    • 0032198323 scopus 로고    scopus 로고
    • Potential application of a chemically modified non-antimicrobial tetracycline (COL-3) against metastatic prostate cancer
    • Lokeshwar BL, Houston-Clark HL, Selzer MG, Block NL, Golub LM. Potential application of a chemically modified non-antimicrobial tetracycline (COL-3) against metastatic prostate cancer. Adv Dent Res 1998;12:97-102.
    • (1998) Adv Dent Res , vol.12 , pp. 97-102
    • Lokeshwar, B.L.1    Houston-Clark, H.L.2    Selzer, M.G.3    Block, N.L.4    Golub, L.M.5
  • 32
    • 0037051090 scopus 로고    scopus 로고
    • Inhibition of cell proliferation, invasion tumor growth and metastasis by an oral non antimicrobial tetracycline analog (Col-3) in a metastatic prostate cancer model
    • Lokeshwar BL, Selzer M, Zhu BQ, Block N, Golub LM. Inhibition of cell proliferation, invasion tumor growth and metastasis by an oral non antimicrobial tetracycline analog (Col-3) in a metastatic prostate cancer model. Int J Cancer 2002;98:297-309.
    • (2002) Int J Cancer , vol.98 , pp. 297-309
    • Lokeshwar, B.L.1    Selzer, M.2    Zhu, B.Q.3    Block, N.4    Golub, L.M.5
  • 33
    • 0025998316 scopus 로고
    • Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in S.C.I.D. mice
    • Wang M, Stearns ME. Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in S.C.I.D. mice. Differentiation 1991;48:115-25.
    • (1991) Differentiation , vol.48 , pp. 115-125
    • Wang, M.1    Stearns, M.E.2
  • 34
    • 0036354866 scopus 로고    scopus 로고
    • Further characterization of human fetal osteoblastic hFOB 1.19 and hFOB/ER alpha cells: Bone formation in vivo and karyotype analysis using multicolor fluorescent in situ hybridization
    • Subramaniam M, Jalal SM, Rickard DJ, Harris SA, Bolander ME. Further characterization of human fetal osteoblastic hFOB 1.19 and hFOB/ER alpha cells: bone formation in vivo and karyotype analysis using multicolor fluorescent in situ hybridization. J Cell Biochem 2002;87:9-15.
    • (2002) J Cell Biochem , vol.87 , pp. 9-15
    • Subramaniam, M.1    Jalal, S.M.2    Rickard, D.J.3    Harris, S.A.4    Bolander, M.E.5
  • 39
    • 1242271208 scopus 로고    scopus 로고
    • 3-Phospoinositide-dependent protein kinase-1/AKT signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer
    • Kulp SK, Yang YT, Hung CC, Chen KF, Lai JP, Tseng PH, Fowble JW, Ward PJ, Chen CS. 3-phospoinositide-dependent protein kinase-1/AKT signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer. Cancer Res 2004;64:144-51.
    • (2004) Cancer Res , vol.64 , pp. 144-151
    • Kulp, S.K.1    Yang, Y.T.2    Hung, C.C.3    Chen, K.F.4    Lai, J.P.5    Tseng, P.H.6    Fowble, J.W.7    Ward, P.J.8    Chen, C.S.9
  • 40
    • 0037568185 scopus 로고    scopus 로고
    • The X-linked inhibitor of apoptosis protein inhibits taxol-induced apoptosis in LNCaP cells
    • Nomura T, Mimata H, Takeuchi Y, Yamamoto H, Miyamoto E, Nomura Y. The X-linked inhibitor of apoptosis protein inhibits taxol-induced apoptosis in LNCaP cells. Urol Res 2003;31:37-44.
    • (2003) Urol Res , vol.31 , pp. 37-44
    • Nomura, T.1    Mimata, H.2    Takeuchi, Y.3    Yamamoto, H.4    Miyamoto, E.5    Nomura, Y.6
  • 41
    • 0041833663 scopus 로고    scopus 로고
    • Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: Effects on cyclooxygenase-2, cell cycle, regulation, and apoptosis mechanism
    • Narayanan BA, Condon MS, Bosland MC, Narayanan NK, Reddy BS. Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle, regulation, and apoptosis mechanism. Clin Cancer Res 2003;9:3503-15.
    • (2003) Clin Cancer Res , vol.9 , pp. 3503-3515
    • Narayanan, B.A.1    Condon, M.S.2    Bosland, M.C.3    Narayanan, N.K.4    Reddy, B.S.5
  • 42
    • 0035650943 scopus 로고    scopus 로고
    • COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib
    • Grosch S, Tegeder I, Niederberger E, Brautigam L, Geisslinger G. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEB J 2001;15:2742-4.
    • (2001) FASEB J , vol.15 , pp. 2742-2744
    • Grosch, S.1    Tegeder, I.2    Niederberger, E.3    Brautigam, L.4    Geisslinger, G.5
  • 43
    • 0030952695 scopus 로고    scopus 로고
    • Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
    • Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997;94:3336-40.
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 3336-3340
    • Tsujii, M.1    Kawano, S.2    DuBois, R.N.3
  • 44
    • 1942438028 scopus 로고    scopus 로고
    • Microtubules as a target for anticancer drugs
    • Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004;4:253-65.
    • (2004) Nat Rev Cancer , vol.4 , pp. 253-265
    • Jordan, M.A.1    Wilson, L.2
  • 45
    • 0025084503 scopus 로고
    • Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung carcinoma cell lines
    • Fridman R, Giaconne G, Kanemoto T, Martin GR, Gazdar AF, Mulshine J. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung carcinoma cell lines. Proc Natl Acad Sci USA 1990;87:6698-702.
    • (1990) Proc Natl Acad Sci USA , vol.87 , pp. 6698-6702
    • Fridman, R.1    Giaconne, G.2    Kanemoto, T.3    Martin, G.R.4    Gazdar, A.F.5    Mulshine, J.6
  • 46
    • 0344825374 scopus 로고    scopus 로고
    • Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death
    • Hazlehurst LA, Landowski TH, Dalton WS. Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death. Oncogene 2003;22:7396-402.
    • (2003) Oncogene , vol.22 , pp. 7396-7402
    • Hazlehurst, L.A.1    Landowski, T.H.2    Dalton, W.S.3
  • 47
    • 0001821119 scopus 로고
    • Selective chemotherapy in relation to the site of tumor transplantation
    • Donelli MG, Russo R, Garrattinin S. Selective chemotherapy in relation to the site of tumor transplantation. Int J Cancer 1975;32: 78-86.
    • (1975) Int J Cancer , vol.32 , pp. 78-86
    • Donelli, M.G.1    Russo, R.2    Garrattinin, S.3
  • 50
    • 0033572578 scopus 로고    scopus 로고
    • Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines
    • Soriano AF, Helfrich B, Chan DC, Heasley LE, Bunn PA, Chou TC. Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines. Cancer Res 1999;59:6178-84.
    • (1999) Cancer Res , vol.59 , pp. 6178-6184
    • Soriano, A.F.1    Helfrich, B.2    Chan, D.C.3    Heasley, L.E.4    Bunn, P.A.5    Chou, T.C.6
  • 51
    • 0003030325 scopus 로고
    • Application of median-effect principle for the assessment of low-dose risk of carcinogenesis and for the quantitation of synergism and antagonism of chemotherapeutic agents
    • Harrap KR, Connors TA, eds. New York: Academic Press
    • Chou TC, Talalay P. Application of median-effect principle for the assessment of low-dose risk of carcinogenesis and for the quantitation of synergism and antagonism of chemotherapeutic agents. In: Harrap KR, Connors TA, eds. New avenues in developmental cancer chemotherapy. New York: Academic Press. 1987.37-64.
    • (1987) New Avenues in Developmental Cancer Chemotherapy , pp. 37-64
    • Chou, T.C.1    Talalay, P.2
  • 52
    • 0141891447 scopus 로고    scopus 로고
    • Synergistic activity of recombinant human endostatin in combination with adriamycin: Analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model
    • Plum SM, Hanson AD, Volker KM, Vu HA, Sim BK, Fogler WE, Fortier AH. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model. Clin Cancer Res 2003;9: 4619-26.
    • (2003) Clin Cancer Res , vol.9 , pp. 4619-4626
    • Plum, S.M.1    Hanson, A.D.2    Volker, K.M.3    Vu, H.A.4    Sim, B.K.5    Fogler, W.E.6    Fortier, A.H.7
  • 53
    • 0034939512 scopus 로고    scopus 로고
    • The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: Curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice
    • Chou TC, O'Connor OA, Tong WP, Guan Y, Zhang ZG, Stachel SJ, Lee C, Danishefsky SJ. The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice. Proc Natl Acad Sci USA 2001;98:8113-8.
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 8113-8118
    • Chou, T.C.1    O'Connor, O.A.2    Tong, W.P.3    Guan, Y.4    Zhang, Z.G.5    Stachel, S.J.6    Lee, C.7    Danishefsky, S.J.8
  • 54
    • 0037123345 scopus 로고    scopus 로고
    • Cyclooxygenase-2, player or spectator in Cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells
    • Song X, Lin HP, Johnson AJ, Tseng PH, Yang YT, Kulp SK, Chen CS. Cyclooxygenase-2, player or spectator in Cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells. J Natl Cancer Inst 2002;94:585-91.
    • (2002) J Natl Cancer Inst , vol.94 , pp. 585-591
    • Song, X.1    Lin, H.P.2    Johnson, A.J.3    Tseng, P.H.4    Yang, Y.T.5    Kulp, S.K.6    Chen, C.S.7
  • 55
    • 0034983860 scopus 로고    scopus 로고
    • Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells
    • Johnson A, Song X, Hsu AL, Chen CS. Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells. Advan Enzyme Regul 2001;41:221-35.
    • (2001) Advan Enzyme Regul , vol.41 , pp. 221-235
    • Johnson, A.1    Song, X.2    Hsu, A.L.3    Chen, C.S.4
  • 56
    • 1542504230 scopus 로고    scopus 로고
    • Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells
    • Bottone FG Jr, Martinez JM, Alston-Mills B, Eling TE. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells. Carcinogenesis 2004;25:349-57.
    • (2004) Carcinogenesis , vol.25 , pp. 349-357
    • Bottone Jr., F.G.1    Martinez, J.M.2    Alston-Mills, B.3    Eling, T.E.4
  • 58
    • 0027992733 scopus 로고
    • Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system
    • Barnett J, Chow J, Ives D, Chiou M, Mackenzie R, Osen E, Nguyen B, Tsing S, Bach C, Freire J. Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim Biophys Acta 1994; 1209:130-9.
    • (1994) Biochim Biophys Acta , vol.1209 , pp. 130-139
    • Barnett, J.1    Chow, J.2    Ives, D.3    Chiou, M.4    Mackenzie, R.5    Osen, E.6    Nguyen, B.7    Tsing, S.8    Bach, C.9    Freire, J.10
  • 59
    • 0642272505 scopus 로고    scopus 로고
    • Celecoxib acts in a cyclooxygenase-2-independent manner and I synergy with emodin to suppress rat cholangiocarcinoma growth in vitro through a mechanism involving enhanced Akt inactivation and increases activation of caspases-9 and 3
    • Lai GH, Zhang Z, Sirica AE. Celecoxib acts in a cyclooxygenase-2- independent manner and I synergy with emodin to suppress rat cholangiocarcinoma growth in vitro through a mechanism involving enhanced Akt inactivation and increases activation of caspases-9 and 3. Mol Cancer Ther 2003;2:265-71.
    • (2003) Mol Cancer Ther , vol.2 , pp. 265-271
    • Lai, G.H.1    Zhang, Z.2    Sirica, A.E.3
  • 60
    • 2342544675 scopus 로고    scopus 로고
    • XIAP as target for therapeutic apoptosis in prostate cancer
    • Devi GR. XIAP as target for therapeutic apoptosis in prostate cancer. Drug News Perspect 2004;17:127-34.
    • (2004) Drug News Perspect , vol.17 , pp. 127-134
    • Devi, G.R.1
  • 61
    • 0034939553 scopus 로고    scopus 로고
    • Selective cyclooxygenase-2 inhibitors: A pattern of neophrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs
    • Perazella MA, Tray K. Selective cyclooxygenase-2 inhibitors: a pattern of neophrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs. Am J Med 2001;111:64-7.
    • (2001) Am J Med , vol.111 , pp. 64-67
    • Perazella, M.A.1    Tray, K.2
  • 62
    • 0034751392 scopus 로고    scopus 로고
    • The ever emerging anti-inflammatories: Have there been any real advances?
    • Rainsford KD. The ever emerging anti-inflammatories: have there been any real advances? J Physiol Paris 2001;95:11-9.
    • (2001) J Physiol Paris , vol.95 , pp. 11-19
    • Rainsford, K.D.1
  • 63
    • 0031960403 scopus 로고    scopus 로고
    • Adverse effects of nonsterodial anti-inflammatory drugs on the gastrointestinal system
    • Fosslien E. Adverse effects of nonsterodial anti-inflammatory drugs On the gastrointestinal system. Ann Clin Sci 1998;28:67-81.
    • (1998) Ann Clin Sci , vol.28 , pp. 67-81
    • Fosslien, E.1
  • 64
    • 0038695146 scopus 로고    scopus 로고
    • Diverse renal effects of anti-inflammatory agents: Evaluation of selective and nonselective cyclooxygenase inhibitors
    • Gambaro G, Perazella MA. Diverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. J Intern Med 2003;253:643-52.
    • (2003) J Intern Med , vol.253 , pp. 643-652
    • Gambaro, G.1    Perazella, M.A.2
  • 65
    • 0035666631 scopus 로고    scopus 로고
    • Celecoxib as adjunctive therapy for treatment of colorectal cancer
    • North GL. Celecoxib as adjunctive therapy for treatment of colorectal cancer. Ann Pharmacother 2001;35:1638-43.
    • (2001) Ann Pharmacother , vol.35 , pp. 1638-1643
    • North, G.L.1
  • 67
    • 0001501848 scopus 로고    scopus 로고
    • Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo
    • Liu XH, Kirschenbaum A, Yao S, Lee R, Holland JF, Levine AC. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol 2000;164:820-5.
    • (2000) J Urol , vol.164 , pp. 820-825
    • Liu, X.H.1    Kirschenbaum, A.2    Yao, S.3    Lee, R.4    Holland, J.F.5    Levine, A.C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.